Bushfield M, Pyne N J, Houslay M D
Department of Biochemistry, University of Glasgow, Scotland.
Eur J Biochem. 1990 Sep 11;192(2):537-42. doi: 10.1111/j.1432-1033.1990.tb19258.x.
Treatment of intact, 32Pi-labelled hepatocytes from lean Zucker rats with a range of agents including 12-O-tetradecanoyl-phorbol 13-acetate (TPA), vasopressin, and angiotensin II elicited substantial increases in the phosphorylation of the alpha-subunit of the inhibitory G protein of adenylate cyclase (alpha Gi-2). These agonist-induced phosphorylations of alpha Gi-2 were associated with loss of Gi function as assessed by the ability of low concentrations of guanylyl 5'-[beta,gamma imido]triphosphate (p[NH]ppG) to inhibit forskolin-stimulated adenylate cyclase activity. Hepatocytes from obese Zucker rats displayed a resistance to both agonist-induced phosphorylation of alpha Gi-2 and to p[NH]ppG-mediated inhibition of adenylate cyclase. The basal level of alpha Gi-2 phosphorylation in hepatocytes from obese Zucker rats was considerably greater at 1.06 +/- 0.09 mol phosphate/mol alpha Gi-2 than in hepatocytes from lean animals which gave 0.54 +/- 0.09 mol phosphate/mol alpha Gi-2. Incubation with TPA (10 ng/ml, 15 min) approximately doubled the level of phosphorylation of alpha Gi-2 in the hepatocytes from lean animals but had little effect on the phosphorylation of alpha Gi-2 in hepatocytes from obese animals. Incubation of hepatocytes from lean animals with ligands which lead to the phosphorylation of alpha Gi-2 abolished the ability of low concentrations of p[NH]ppG to inhibit adenylate cyclase expressed in isolated membranes. Treatment of hepatocyte plasma membranes from lean but not obese Zucker rats with pure protein kinase C led to the phosphorylation of alpha Gi-2. The resistance to protein-kinase-C-mediated phosphorylation in hepatocyte membranes from obese animals could be overcome by treatment of the membranes with alkaline phosphatase. These results indicate that the defect in guanine-nucleotide-mediated 'Gi function' seen in obese Zucker rats may be due to an inactivating phosphorylation of alpha Gi-2.
用一系列试剂(包括12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)、血管加压素和血管紧张素II)处理来自瘦型 Zucker 大鼠的完整、32P 标记的肝细胞,可引起腺苷酸环化酶抑制性 G 蛋白的α亚基(αGi - 2)磷酸化显著增加。这些激动剂诱导的αGi - 2磷酸化与 Gi 功能丧失有关,这是通过低浓度鸟苷酰5'-[β,γ - 亚氨基]三磷酸(p[NH]ppG)抑制福斯可林刺激的腺苷酸环化酶活性的能力来评估的。肥胖 Zucker 大鼠的肝细胞对激动剂诱导的αGi - 2磷酸化和 p[NH]ppG介导的腺苷酸环化酶抑制均表现出抗性。肥胖 Zucker 大鼠肝细胞中αGi - 2磷酸化的基础水平在1.06±0.09摩尔磷酸盐/摩尔αGi - 2时明显高于瘦型动物肝细胞,瘦型动物肝细胞的该水平为0.54±0.09摩尔磷酸盐/摩尔αGi - 2。用TPA(10 ng/ml,15分钟)孵育使瘦型动物肝细胞中αGi - 2的磷酸化水平增加约一倍,但对肥胖动物肝细胞中αGi - 2的磷酸化影响很小。用导致αGi - 2磷酸化的配体孵育瘦型动物肝细胞后,低浓度p[NH]ppG抑制分离膜中表达的腺苷酸环化酶的能力丧失。用纯蛋白激酶C处理瘦型而非肥胖 Zucker 大鼠的肝细胞质膜会导致αGi - 2磷酸化。用碱性磷酸酶处理肥胖动物肝细胞膜可克服其对蛋白激酶C介导的磷酸化的抗性。这些结果表明,肥胖 Zucker 大鼠中所见的鸟嘌呤核苷酸介导的“Gi功能”缺陷可能是由于αGi - 2的失活磷酸化所致。